Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-16

Clinical Trial Update: Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase [Phase 3]

View source ↗

Summary

Phase 3 trial update on initiating ovarian stimulation with recombinant human FSH (Bemfola) in the late follicular phase for infertility in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bemfola (follitropin alfa)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Infertility, Female | Phase 3 | Status: COMPLETED